Position in ABCL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,684,468
-$5,123 QoQ
Shares Held
1,870,633
-55.6% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 150 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,570,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ABCL ranks #97 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ABCL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,684,468 | 1,870,633 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $1,570,000 | 200,000 | Put | Defined | 2026-08-13 | |
| 2026-03-31 | $14,689,591 | 4,209,052 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,632,778 | 1,939,409 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $12,520,674 | 2,489,200 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,826,382 | 3,447,925 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,333,268 | 5,082,183 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,787,769 | 1,975,348 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $56,536 | 21,745 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $281,171 | 94,991 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $461,946 | 101,975 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14,275 | 2,500 | Shares | Defined | 2024-02-09 | |
| 2023-06-30 | $86,344 | 13,366 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $504,410 | 66,898 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $448,211 | 44,246 | Shares | Defined | 2023-02-08 | |
| 2022-12-31 | $303,900 | 30,000 | Call | Defined | 2023-02-08 | |
| 2022-09-30 | $937,947 | 94,838 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $2,463,599 | 249,100 | Call | Defined | 2022-11-10 | |
| 2022-06-30 | $440,430 | 41,355 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $608,643 | 62,425 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,132,430 | 79,191 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,270,676 | 63,407 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $902,396 | 41,018 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $104,223 | 3,069 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $321 | 8 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||